Wed, Sep 18, 2019
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

Dealmakers Q&A: MedMen eye second fund

Friday, September 29, 2017

By: Bailey McCann, Private Equity Strategies

Los Angeles, California-based cannabis-focused investment firm MedMen is eying its second fund. The firm is targeting $250 million for investments in cannabis assets.

MedMen's investor base is largely high net worth individuals and family offices, but the firm has also had some institutional interest. MedMen partnered with Chicago-based Wicklow Capital, a venture capital firm, for investments from its first fund which closed on just under $100 million earlier this year. Wicklow Capital is backed by Dan Tierney, the co-founder and former board member of GETCO, a Chicago-based high-frequency trading firm, now known as KCG Holdings following GETCO's acquisition of Knight Capital in 2013. MedMen typically invests between $1-40 million per transaction and made seven investments from its debut fund.

Unlike other cannabis industry investors that are focused on investing in existing consumer distributors, MedMen invests in raw assets. The firm is looking for opportunities to buy licenses or cannabis assets that they can then turn into an enterprise. MedMen operates by using a management holding company model, so they are the owners of each entity in the portfolio, rather than simply investing in several companies.

"We made a strategic decision to be very hands-on with development," MedMen co-Chairman and Partner, Chris Leavy tells Private Equity Strategies. Leavy oversees the investment strategy for the firm. Prior to joining MedMen, Leavy spent more than two decades on Wall Street, holding senior management roles at Morgan Stanley, OppenheimerFunds, and BlackRock.

According to Leavy, the development model MedMen uses is more resource intensive, but it allows the firm to be a prime mover in the still nascent industry. "We are working on everything from regulatory, to site selection, to bringing in people with relevant experience," he explains. "Many people look at us as a pot business, but we are largely working with experts from other fields including agriculture, chemistry, consumer marketing, finance. We are creating a new industry."

MedMen has an established presence in states that allow medical marijuana and is expanding its footprint into emerging medical markets including Massachusetts, New York, and Nevada.

In some ways, the firm operates like a large mid-market specialist private equity manager. Because of the focus on a single industry, Leavy and the investment team can take advantage of common private equity scaling practices like group purchasing, group marketing, and supply chain optimization. For Leavy, that model is key to MedMen's growth prospects because he says, it creates standardization and opportunity in an otherwise inefficient and fragmented market. "We're still early enough into the development of the industry that people are trying a lot of different models," he says. "This isn't available in every state. So if we can come in and build scale, there is opportunity for us there."

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Albright Capital builds on emerging markets impact strategy, signs on to IFC principles[more]

    Bailey McCann, Opalesque New York: Albright Capital has adopted the International Finance Corporation's Operating Principles for Impact Management. The firm has also developed its own impact measurement system as part of the implementation of the principles. The IFC's principles were

  2. Investing: Hedge funds getting burned as growth stocks trounced by value, Why investors are prioritizing health care in a big way, Fannie, Freddie soar as hedge funds score wins on two fronts[more]

    Hedge funds getting burned as growth stocks trounced by value From Bloomberg: A hedge-fund favorite is rapidly losing ground in the stock market just as one of the industry's least-loved sectors picks up. Growth stocks, generally companies that are seeing rapid profit increases, have drop

  3. PE/VC: Supersized unicorn: Root Insurance leaps to $3.65bn valuation with $350m round[more]

    Root Insurance is now valued at $3.65 billion after a $350 million funding round - the largest single venture capital round ever in the state. The 3-year-old auto insurer, now the startup with the highest valuation of any in Ohio, has raised a cumulative $523 million in VC and another $100 mi

  4. Testing hedge performance when stocks crash[more]

    Bonds have historically been a reliable buffer for stock exposure. But low yields and potential reversion to a more positive stock/bond correlation would likely translate to less protection. Gold has been a solid crisis hedge but has experienced long stretches of negative inflation-adjusted returns.

  5. PE/VC: The FBI is investigating a venture capital fund started by Peter Thiel for financial misconduct, Why venture capital firms need more women partners and entrepreneurs[more]

    The FBI is investigating a venture capital fund started by Peter Thiel for financial misconduct From Vox: Federal investigators are probing the conduct and practices of Mithril Capital, a venture capital firm co-founded by Peter Thiel, Recode has learned. US officials - including t